Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Immunoblastic Lymphadenopathy × Celecoxib × Clear all

Sponsor

Conditions

Colorectal Neoplasms 9 Breast Neoplasms 9 Colonic Neoplasms 5 Carcinoma, Non-Small-Cell Lung 5 Rectal Neoplasms 4 Lung Neoplasms 4 Head and Neck Neoplasms 4 Adenomatous Polyposis Coli 4 Sarcoma 3 Glioblastoma 3 Central Nervous System Neoplasms 3 Paranasal Sinus Neoplasms 2 Neoplasms 2 Mouth Neoplasms 2 Melanoma 2 Laryngeal Neoplasms 2 Gliosarcoma 2 Breast Carcinoma In Situ 2 Uterine Cervical Neoplasms 1 Uterine Cervical Dysplasia 1 Unspecified Adult Solid Tumor, Protocol Specific 1 Triple Negative Breast Neoplasms 1 Tobacco Use Disorder 1 Stomatitis 1 Smoldering Multiple Myeloma 1 Smoking 1 Recurrence 1 Prostatic Neoplasms 1 Prostatic Hyperplasia 1 Precancerous Conditions 1

Interventions

fludarabine phosphate 15 Cyclophosphamide 13 Whole-Body Irradiation 12 Peripheral Blood Stem Cell Transplantation 12 Tacrolimus 10 Etoposide 10 Rituximab 8 Mycophenolic Acid 8 Methotrexate 6 Melphalan 6 Cyclosporine 6 Busulfan 6 Antilymphocyte Serum 6 Vorinostat 4 Sirolimus 4 Prednisone 4 Lenalidomide 4 Immunohistochemistry 4 Gene Expression Profiling 4 Carboplatin 4 Vincristine 3 Microarray Analysis 3 Gemcitabine 3 Everolimus 3 Doxorubicin 3 Dexamethasone 3 Brentuximab Vedotin 3 Alemtuzumab 3 10-propargyl-10-deazaaminopterin 3 thymoglobulin 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡